FDA Drug Recalls

Recalls / Class II

Class IID-1500-2014

Product

Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90-tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC # 59746-339-90

Brand name
Losartan Potassium And Hydrochlorothiazide
Generic name
Losartan Potassium And Hydrochlorothiazide
Active ingredients
Hydrochlorothiazide, Losartan Potassium
Route
Oral
NDCs
59746-337, 59746-338, 59746-339
FDA application
ANDA201845
Affected lot / code info
Lot #14P0292, Exp 04/2016

Why it was recalled

Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.

Recalling firm

Firm
Jubilant Cadista Pharmaceuticals Inc.
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
207 Kiley Dr, Salisbury, Maryland 21801-2249

Distribution

Quantity
9,358 bottles
Distribution pattern
Nationwide and Puerto Rico

Timeline

Recall initiated
2014-07-11
FDA classified
2014-07-31
Posted by FDA
2014-08-06
Terminated
2016-09-15
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1500-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.